— Fast Track Designation facilitates development and expedites regulatory review of therapies addressing serious conditions with significant unmet medical need — — QRX003 lotion (4%) currently being ...
The U.S. Food and Drug Administration (FDA) has approved a once-daily GLP-1 pill for weight loss called orforglipron (marketed as Foundayo) for adults with obesity or those who are overweight and have ...
Fast Track is an FDA program designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need. Its purpose is to help important new ...
NASHVILLE, Tenn., Feb. 4, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on developing new products for rare diseases, announced today ...
The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by ...
The Dermatology Division of the U.S. Food and Drug Administration has granted Fast Track designation to sonelokimab in moderate-to-severe palmoplantar pustulosis supported by positive results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results